CLAYENS Healthcare represents the Healthcare activities of the CLAYENS Group. We offer complete support to Healthcare players for the development, industrialization and manufacturing of their Medical/Pharmaceutical devices and plastic components, in compliance with international regulatory requirements. The CLAYENS Group (5500 employees, 33 plants worldwide and 700M€ turnover) supports its customers in the medical sector (medical devices, pharmaceuticals and diagnostics) from idea to product: design, prototyping, industrialization, qualification and validation, regulatory support and production with 12 Healthcare manufacturing sites in France, USA, Mexico and Poland, including 9 cleanrooms (ISO7 & ISO8). The 12 Healthcare Plants of the CLAYENS Group (among 33 Plants worldwide) : In Europe: - CLAYENS NP Plastibell (Izernore, France) - CLAYENS NP Piaseczno (Piaseczno, Poland) - CLAYENS NP Jura (Dole, France) - CLAYENS NP Savoie (Belmont Tramonet, France) - CLAYENS NP Sud (Beauchastel, France) - AIP Medical (Chassieu, France) In North America: - CLAYENS Crystal Lake (Crystal Lake, IL, USA) - CLAYENS Mexico (Torreon, Mexico) - CLAYENS Providence (East Providence, RI, USA) - CLAYENS Wallingford (Wallingford, CT, USA) - CLAYENS Loveland (Loveland, CO) - CLAYENS Chihuahua (Chihuahua, Mexico) Some examples of our Healthcare products: components, sub-assemblies or finished medical devices, among which delivery devices like syringes (pre-filled and non-prefilled), auto-injectors and aerosols, surgical kits and orthopedic implants, in-vitro diagnostic devices, hospital kits, safety products, medical equipment components,... For more information: https://www.clayens-np.com/healthcare